Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules
Preliminary data shows 78% fusion rate vs 42% for autograft and 55-71% for other synthetic bone grafts Level 1 clinical…
Preliminary data shows 78% fusion rate vs 42% for autograft and 55-71% for other synthetic bone grafts Level 1 clinical…
With immediate effect, Dr. Jürgen O. Böhm will take on the role of corporate management at Hemovent GmbH. As the new Chi…
Seal of quality for medical technology: after successful auditing by TÜV Süd, PreciPoint GmbH, which specializes in digi…
Dentsply Sirona today announced that Simon Campion has been appointed President and Chief Executive Officer and will joi…
Soft, moldable formulation that is ready to use with no need for thawing or mixing Becomes third commercial MagnetOs pro…
Accelerated growth and stronger focus on photonics Expansion of global presence in attractive markets, predominantly…
Das Medizintechnik-Unternehmen Richard Wolf GmbH unterstützt als Corporate Sponsor die internationale Gesellschaft ISFGS…
Agreements in Netherlands, Switzerland and Austria and letter of intent in Finland Supports further acceleration of sale…
Linde (NYSE: LIN; FWB: LIN), announced today that its joint venture, Linde LienHwa (LLH), will invest approximately USD…
Linde (NYSE:LIN; FWB:LIN) announced today that it has started up a new SPECTRA high purity nitrogen generator to support…